AVI BioPharma Announces $24 Million Direct Equity Placement
25-Jan-2005
The securities are being sold pursuant to the company's effective shelf registration statement. Rodman & Renshaw, LLC, acted as the exclusive placement agent on the transaction.
Most read news
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.